The Respiratory Virus Hospitalization Study (FLU 003 Plus) enrolls individuals with influenza who were hospitalized with complications or severe disease and individuals with a suspected or confirmed diagnosis of a targeted non-influenza viral respiratory infection, e.g., MERS-CoV, in addition to confirmed or suspected influenza, and follows their clinical course for 60 days